Ikarian Capital, LLC Yumanity Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.99 $134,529 - $262,465	-131,892 Reduced 55.82%	104,392 $190,000
Q1 2022 May 13, 2022	BUY	$0.97 - $3.27 $7,297 - $24,600	7,523 Added 3.29%	236,284 $355,000
Q3 2021 Nov 15, 2021	BUY	$8.3 - $12.04 $77,115 - $111,863	9,291 Added 4.23%	228,761 $2.36 Million
Q1 2021 May 17, 2021	BUY	$16.69 - $22.52 $1.45 Million - $1.96 Million	86,956 Added 65.62%	219,470 $3.97 Million
Q4 2020 Feb 12, 2021	BUY	$16.67 - $25.4 $2.21 Million - $3.37 Million	132,514 New	132,514 $2.25 Million

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.